Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 17:11:594735.
doi: 10.3389/fimmu.2020.594735. eCollection 2020.

The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside

Taoming Liu  1 , Sheng Li  1 , Shuni Ying  1 , Shunli Tang  1 , Yuwei Ding  1 , Yali Li  1 , Jianjun Qiao  1 , Hong Fang  1
Affiliations
Review

The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside

Taoming Liu et al. Front Immunol. .

Abstract

Interleukin-17 (IL-17) is an essential proinflammatory cytokine, which is mainly secreted by the CD4+ helper T cells (Th17 cells) and subsets of innate lymphoid cells. IL-17A is associated with the pathogenesis of inflammatory diseases, including psoriasis, atopic dermatitis, hidradenitis suppurativa, alopecia areata, pityriasis rubra pilaris, pemphigus, and systemic sclerosis. Interleukin-23 (IL-23) plays a pivotal role in stimulating the production of IL-17 by activating the Th17 cells. The IL-23/IL-17 axis is an important pathway for targeted therapy for inflammatory diseases. Emerging evidence from clinical trials has shown that monoclonal antibodies against IL-23, IL-17, and tumor necrosis factor are effective in the treatment of patients with psoriasis, atopic dermatitis, hidradenitis suppurativa, pityriasis rubra pilaris, pemphigus, and systemic sclerosis. Here, we summarize the latest knowledge about the biology, signaling, and pathophysiological functions of the IL-23/IL-17 axis in inflammatory skin diseases. The currently available biologics targeting the axis is also discussed.

Keywords: IL-17 family; IL-23; IL-23/IL-17 axis; psoriasis; targeted therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
IL-23/IL-17 signaling transduction. IL-23 is important in differentiation of Th17 cells, by promoting the production of IL-17A, IL-17F, TNF, and IL-6. IL-23 is heterodimeric and composed of IL-12p40 and IL-23p19. Binding to its receptors, IL-23 involves in phosphorylation of JAKs and TYK, as well as phosphorylation and dimerization of STAT3. Subsequently, STAT3 homodimers regulates the expression of ROR-γt to promote the gene expression. The combination of IL-17A/A, IL-17A/F, or IL-17F/F cytokine with IL-17RA and IL-17RC is found to be a crucial complex of immune response. IL-17R acts on Act1 through interaction platform of the SEFIR domain. Upon ligand binding, Act1 activates NF-κB, C/EBP family, and MAPK pathway by inducing various TRAF proteins. Act1 is essential for mediating ubiquitination of TRAF6, then TRAF6 triggers a positive reaction in multiple different pathways. TRAF6 recruits and stimulates the TAK1 and IKK complex, leading to activation of NF-κB pathway. IL-17R-Act1 complex together with TRAF4, MEKK3, and MEK5 to promote activation of ERK5. In addition, ACT1-TRAF2-TRAF5 complex is capable to maintain the mRNA stability targeting the IL-17 gene. The inhibitors A20 and TRAF3 are linked with IL-17RA, dependent on the CBAD. C/EBP, CCAAT/enhancer-binding proteins; NF-κB, canonical nuclear factor-κB; MAPK, mitogen-activated protein kinase; TRAF, tumor necrosis factor receptor associated factor; TAK1, transforming growth factor-β activated kinase 1; IKK, inhibitor of kappa B kinase; ERK5, extracellular signal-regulated kinase 5; RORγt, retinoid-related orphan receptor-γt; STAT3, signal transducer and activator of transcription 3; JAK2, Janus activated kinase 2; TYK2, tyrosine kinase 2.
Figure 2
Figure 2
T-cell immune axis and associated cytokines in the pathogenesis of psoriasis, hidradenitis suppurativa, atopic dermatitis, and alopecia areata. (A) Psoriasis develops through the aberrant activation of the dendritic cells producing IL-12 and IL-23. The dendritic cells induce the differentiation of the Th 17 cells and Th1 cells. IL-23 promotes the Th17 cells to secrete IL-17, IL-22, and TNF-α. In keratinocytes, IL-17 also stimulates production of antimicrobial peptides (S100A7/A8/A9 proteins and beta defensins). These cytokines promote keratinocyte proliferation and neutrophil recruitment, resulting in the formation of psoriatic plaques. (B) In hidradenitis suppurativa, the T cells involved in the pathogenesis of hidradenitis suppurativa include the Th1 and Th17 cells. IL-23 induces the differentiation of the Th17 cells and overexpression of IL-17. IL-17 induces the expression of the proinflammatory proteins (S100A8/A9) and NLRP3 in the keratinocytes. More inflammatory cytokines are recruited to the follicular unit and perilesional skin. (C) In atopic dermatitis, with impairment of the skin barrier in patients with atopic dermatitis, the damaged keratinocytes produce inflammatory cytokines (IL-17E). The cytokines stimulate the ILC2s to secrete type 2 cytokines (IL-5 and IL-13). IL-17E also inhibits the synthesis of FLG. IL-4, IL-13, and IL-31 directly stimulate the sensory nerves to promote pruritus. (D) In alopecia areata, the elevated IFN-γ levels in the perifollicular area activate the differentiation of the CD4+ T cells into various types of T cells, as shown. Th17 cells act on the hair follicle by producing proinflammatory mediators (IL-17, IL-21, IL-22, and IL-26), ultimately leading to the disruption of hair growth. TNF, tumor necrosis factor; NLRP3, NACHT, LRR, and NACHT, LRR, and PYD domains-containing protein 3; FLG, filaggrin; ILC2s, type 2 innate lymphoid cells; DC, dendritic cell.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Rouvier E, Luciani MF, Mattéi MG, Denizot F, Golstein P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol (1993) 150(12):5445–56. - PubMed
    1. Zhou J, An X, Dong J, Wang Y, Zhong H, Duan L, et al. IL-17 induces cellular stress microenvironment of melanocytes to promote autophagic cell apoptosis in vitiligo. FASEB J (2018) 32(9):4899–916. 10.1096/fj.201701242RR - DOI - PubMed
    1. Zepp JA, Zhao J, Liu C, Bulek K, Wu L, Chen X, et al. IL-17A-Induced PLET1 Expression Contributes to Tissue Repair and Colon Tumorigenesis. J Immunol (2017) 199(11):3849–57. 10.4049/jimmunol.1601540 - DOI - PMC - PubMed
    1. Burstein VL, Guasconi L, Beccacece I, Theumer MG, Mena C, Prinz I, et al. IL-17-Mediated Immunity Controls Skin Infection and T Helper 1 Response during Experimental Microsporum canis Dermatophytosis. J Invest Dermatol (2018) 138(8):1744–53. 10.1016/j.jid.2018.02.042 - DOI - PubMed
    1. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol (2005) 6(11):1133–41. 10.1038/ni1261 - DOI - PMC - PubMed

Publication types